SYSADOAs: do their origin and quality make a difference in efficacy and safety?
Symptomatic slow-acting drugs for osteoarthritis (SYSADOAs) comprise a heterogeneous group of drugs with a long-term effect on the symptoms of osteoarthritis. The most widely used agents—chondroitin sulfate, glucosamine, and diacerein—have been recommended by the European League Against Rheumatism (...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Panamerican League of Associations of Rheumatology (PANLAR)
2021-03-01
|
| Series: | Global Rheumatology |
| Subjects: | |
| Online Access: | https://www.globalrheumpanlar.org/manuscrito-articulo-de-revision/sysadoas-do-their-origin-and-quality-make-difference-efficacy-and?language=en |